Asthma Clinical Trial
Official title:
Exercise Challenge Test in 3-6 Years Old Asthmatic Children
Vigorous exercise is known to cause transient bronchoconstriction in school children with
asthma, many of whom initially have normal lung function at rest. The presence and extent of
this phenomena in early childhood is difficult to recognize, because exercise induced
bronchoconstriction (EIB) may not limit the child's performance and the child may fail to
notice the symptoms until taking part in organized or competitive sport. Conversely, as
children do participate in vigorous activities all day long, severe EIB may provoke a
crucial disabling condition in the child.
In school children the exercise challenge test (ECT) is a well standardized test and is used
to make a diagnosis of asthma because it is able to discriminate between asthma and other
chronic breathing illnesses of childhood and is also used to determine the effectiveness and
optimal dosages of medications prescribed to prevent EIB.
The test includes is a controlled run on a motor-driven treadmill followed by scheduled
multiple spirometry maneuvers. This procedure was never been tested and may not be suitable
for the preschool age.
In this study we assumed that a free-run test which combined with measurements of duplicate
spirometry-sets would be the most convenient way to test young children.
The aims of this study are a) to examine the feasibility of a free-run protocol (according
to the ATS/ERS recomendations), followed by duplicate spirometry measurements in early
childhood.
b) to explore the existence of exercise induced bronchoconstriction in young children (age
3-6 years old) with respiratory symptoms.
Method:
The children are to come in comfortable clothes and running shoes, having consumed no more
than a light meal and having had pulmonary medications withdrawn as described above. A
parent, a pediatric pulmonary physician and a technician is present throughout the test.
Each child undergoes a physical examination to exclude evidence of wheeze, and baseline
spirometry was performed. The children are asked to run freely back and forth (without a
nose-clip) in a 50m long corridor next to the pulmonary laboratory. The target is to achieve
6 minutes of "free run" to increase hart-rate to 80% in the maximum for at least 4 minutes
according to ATS/ERS recommendations for exercise challenge test in older children [1]. An
adult (parent/technician/ physician) will run with the child to encourage him/her to
continue running. Heart-rate and O2-saturation is monitored continuously throughout the run
using a portable mobile pulse-oximeter monitor (Nonin medical, INC, model 2500, Minneapolis,
USA).
Spirometry is measured according to the recommendations for preschool children [2], with a
commercial ZAN100 Spirometer situated in the pediatric pulmonary laboratory, by a skilled
technician. Measurements are performed in the standing position, without nose-clip (for
comfort of the child) until two consecutive technically acceptable curves are achieved.
After the free-run, spiroetmry is measured in duplicate sets at 1, 3, 5, 10 and 20 minutes
post-exercise [1]. The better of the two curves is selected as the representative value at
each interval, but differences between the two values of FEV1 has to be <5%. The following
signs are monitored by the pulmonologist: wheeze and prolonged expiration on auscultation
over the trachea and two zones of both lungs (upper front and lower back). Cough, shortness
of breath, or perceived breathlessness within 20 minutes after the run were noted.
Analysis: Technically acceptable spirometry maneuvers are analyzed. Baseline values are
first compared to the spirometry values with relation to height derived from the indices in
109 healthy children in our previous study [3].
Following exercise, best spirometry values for each interval are compared to baseline
values. Exercise response was defined as the greatest decrease in FEV1 expressed as a
percentage of the baseline values. A bronchoconstriction response to exercise is considered
as positive when the FEV1 decrease from baseline was greater than 13% [4]. Student’s paired
t-test is used for comparison of data between each spirometry index and the calculated
values for healthy children. A value of p<0.05 was considered significant.
References:
1. Guidelines for Methacholine and Exercise Challenge Testing 1999. The official
statements of the American Thoracic Society, adopted by the ATS board of directors,
1999. Am J Respir Crit. Care Med 2000;161:309-329.
2. Aurora P, Stocks J, Oliver C, Saunders C, Castle R, Chaziparasidis G, Bush A; London
Cystic Fibrosis Collaboration. Quality control for spirometry in preschool children
with and without lung disease. Am J Respir Crit Care Med 2004; 169:1152-1159.
3. Vilozni D, Barak A, Efrati O, Augarten A, Springer C, Yahav Y, Bentur L. The role of
computer games in measuring spirometry in healthy and "asthmatic" preschool children.
Chest. 2005; 128:1146-115.
4. Godfrey S, Springer C, Bar-Yishay E, Avital A. Cut-off points defining normal and
asthmatic bronchial reactivity to exercise and inhalation challenges in children and
young adults. Eur Respir J. 1999; 14:659-66.
;
Allocation: Random Sample, Primary Purpose: Screening, Time Perspective: Cross-Sectional
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04624425 -
Additional Effects of Segmental Breathing In Asthma
|
N/A | |
| Terminated |
NCT04410523 -
Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma
|
Phase 2 | |
| Active, not recruiting |
NCT03927820 -
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
|
N/A | |
| Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
| Recruiting |
NCT03694158 -
Investigating Dupilumab's Effect in Asthma by Genotype
|
Phase 4 | |
| Terminated |
NCT04946318 -
Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma
|
Phase 2 | |
| Completed |
NCT04450108 -
Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients
|
N/A | |
| Completed |
NCT03086460 -
A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)
|
Phase 2 | |
| Completed |
NCT01160224 -
Oral GW766944 (Oral CCR3 Antagonist)
|
Phase 2 | |
| Completed |
NCT03186209 -
Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)
|
Phase 3 | |
| Completed |
NCT02502734 -
Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma
|
Phase 3 | |
| Completed |
NCT01715844 -
L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics
|
Phase 1 | |
| Terminated |
NCT04993443 -
First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036
|
Phase 1 | |
| Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
| Recruiting |
NCT06033833 -
Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study
|
Phase 2 | |
| Completed |
NCT03257995 -
Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.
|
Phase 2 | |
| Completed |
NCT02212483 -
Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients
|
N/A | |
| Recruiting |
NCT04872309 -
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
|
||
| Withdrawn |
NCT01468805 -
Childhood Asthma Reduction Study
|
N/A | |
| Recruiting |
NCT05145894 -
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
|